Roth Capital Initiates Coverage On Applied Genetic Tech with Buy Rating, Announces $25 Price Target

Roth Capital analyst Zegbeh Jallah initiates coverage on Applied Genetic Tech (NASDAQ:AGTC) with a Buy rating and a $25 price target.

Benzinga · 01/28/2020 11:27

Roth Capital analyst Zegbeh Jallah initiates coverage on Applied Genetic Tech (NASDAQ:AGTC) with a Buy rating and a $25 price target.